Accretion Pharmaceuticals
ACCPLNSE

Accretion Pharmaceuticals

₹156.502.50 (1.62%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
156.50
Today’s high
161.65
52 week low
53.80
52 week high
171.15
Open price
161.65
Previous close
154.00
Live volume
6,000
Lower circuit
146.30
Upper circuit
161.70

Fundamentals

Market Cap
₹171Cr
ROE
17.67%
P/E Ratio(TTM)
17.70
EPS(TTM)
8.70
P/B Ratio
3.13
Dividend Yield
0.00%
Industry P/E
47.83
Book Value
49.21
Debt to Equity
0.23
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2025
Revenue (Cr)
₹57.47
+328.65%
Profit (Cr)
₹6.79
+355.08%
015304560
2024
2025

About

Accretion Pharmaceuticals Limited is engaged in the trading and marketing of pharmaceutical formulations and healthcare products.;
CEO/MD
Vivek Ashok Kumar Patel
Founded in
2015
NSE symbol
ACCPL

Shareholding Pattern

Mar '26
Dec '25
Sep '25
Jun '25
May '25
Promoters
73.50%
Retail And Others
26.50%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹857.40
-6.15 (0.71%)
L
    H
    21,393.5535.964.21
    PfizerPFIZER
    ₹4,565.00
    +26.30 (0.58%)
    L
      H
      20,747.9728.724.94
      ₹8,176.50
      -27.50 (0.34%)
      L
        H
        20,500.13109.3223.49
        ₹1,418.10
        -17.00 (1.18%)
        L
          H
          19,908.8830.745.1
          Recent news is not available for this stock
          2026
          8
          May
          Annual Result
          Release date
          2025
          14
          Nov
          Result
          Release date
          Events calendar
          View upcoming events in other stocks